These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 6214989)
1. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers. Srinivasan S; Fu KP; Neu HC Antimicrob Agents Chemother; 1981 Feb; 19(2):302-5. PubMed ID: 6214989 [TBL] [Abstract][Full Text] [Related]
2. Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects. Scheld WM; Spyker DA; Donowitz GR; Bolton WK; Sande MA Antimicrob Agents Chemother; 1981 Apr; 19(4):613-9. PubMed ID: 6454387 [TBL] [Abstract][Full Text] [Related]
3. Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion. Polk RE; Kline BJ; Markowitz SM Antimicrob Agents Chemother; 1981 Nov; 20(5):576-9. PubMed ID: 6459759 [TBL] [Abstract][Full Text] [Related]
5. Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion. Polk R; Hume A; Kline BJ; Cardea J Clin Orthop Relat Res; 1983; (177):216-21. PubMed ID: 6222858 [TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers. Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967 [TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology of moxalactam in patients with malignant disease. Estey EH; Weaver SS; Ho DH; Bodey GP Antimicrob Agents Chemother; 1981 Apr; 19(4):639-44. PubMed ID: 6454389 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers. Parsons JN; Romano JM; Levison ME Antimicrob Agents Chemother; 1980 Feb; 17(2):226-8. PubMed ID: 6446259 [TBL] [Abstract][Full Text] [Related]
9. Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects. Israel KS; Black HR; Brier GL; Wolny JD; DeSante KA Antimicrob Agents Chemother; 1982 Jul; 22(1):94-102. PubMed ID: 6214998 [TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. Schaad UB; McCracken GH; Threlkeld N; Thomas ML J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of moxalactam in patients with renal insufficiency. Lam M; Manion CV; Czerwinski AW Antimicrob Agents Chemother; 1981 Mar; 19(3):461-4. PubMed ID: 6454383 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis. Srinivasan S; Neu HC Antimicrob Agents Chemother; 1981 Sep; 20(3):398-400. PubMed ID: 6458236 [TBL] [Abstract][Full Text] [Related]
13. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic. Neu HC Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787 [TBL] [Abstract][Full Text] [Related]